Min Jin, Shengli Yang, Junli Liu, Jieying Zhang, Lei Zhao, Dandan Yu, Zhenyu Lin, Pindong Li, Jing Wang, Jun Xue, Hong Ma, Jianli Hu, Tao Zhang, Hongli Liu. "A phase II study of fruquintinib plus sintilimab as a second-line therapy for advanced gastric and gastroesophageal junction adenocarcinoma (GC/GEJC): Updated results.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.407